Glenmark Snaps Up Exeltis Derma Range, Sets Base For US Brands Play

 
• By Anju Ghangurde

Glenmark Pharmaceuticals has tiptoed into the US branded dermatology segment by buying out a range of products from Exeltis. It hopes to build on this base with additional assets, alongside its generics business.

SC1808_Biz-Puzzle_1005619939_1200.jpg
GLENMARK PLANS TO STRADDLE THE US BRANDS SEGMENT ALONGSIDE GENERICS

More from Dermatological

More from Therapy Areas